105 related articles for article (PubMed ID: 2325572)
1. Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.
Tilyard M
Metabolism; 1990 Apr; 39(4 Suppl 1):50-2. PubMed ID: 2325572
[TBL] [Abstract][Full Text] [Related]
2. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
3. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
Gallagher JC; Goldgar D
Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
[TBL] [Abstract][Full Text] [Related]
4. Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate.
Gallagher JC; Riggs BL
Metabolism; 1990 Apr; 39(4 Suppl 1):30-4. PubMed ID: 2325569
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
Gallagher JC
Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with calcitriol in postmenopausal osteoporosis.
Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
[TBL] [Abstract][Full Text] [Related]
7. Role of calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF
Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol treatment is not effective in postmenopausal osteoporosis.
Ott SM; Chesnut CH
Ann Intern Med; 1989 Feb; 110(4):267-74. PubMed ID: 2913914
[TBL] [Abstract][Full Text] [Related]
12. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption.
Need AG; Nordin C; Horowitz M; Morris HA
Metabolism; 1990 Apr; 39(4 Suppl 1):53-4. PubMed ID: 2325573
[TBL] [Abstract][Full Text] [Related]
13. Treatment of postmenopausal osteoporosis.
Lloyd M
N Engl J Med; 1998 Jul; 339(3):202; author reply 203. PubMed ID: 9669921
[No Abstract] [Full Text] [Related]
14. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
Gallagher JC
J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
Richy F; Ethgen O; Bruyere O; Reginster JY
Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
[TBL] [Abstract][Full Text] [Related]
16. Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.
Holzherr ML; Retallack RW; Gutteridge DH; Price RI; Faulkner DL; Wilson SG; Will RK; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Kent GN; Bhagat CI; Dhaliwal SS; Jamrozik K
Osteoporos Int; 2000; 11(1):43-51. PubMed ID: 10663358
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
[TBL] [Abstract][Full Text] [Related]
18. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcitriol on bone loss after cardiac or lung transplantation.
Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]